Debomita Chakraborty

Employment

• Universitätsmedizin Mainz Scientific researcher
  2023 - Present
• University hospital Erlangen Post-Doc
  2022 - 2023
• Universitätsklinikum Erlangen research employee and PhD
  ? - 2023

Education

• Indian Institute of Technology Kharagpur Master of Technology (MTech)
  2013 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Integrate and conquer: pan-cancer proteogenomics uncovers cancer vulnerabilities and therapeutic opportunities
  Signal Transduction and Targeted Therapy 2024 0 citations DOI: 10.1038/s41392-024-02009-6
  +Save
• Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis
  Journal of Clinical Investigation 2024 1 citation DOI: 10.1172/JCI159884
  +Save
• An Introduction to Organoids, Organoid Creation, Culture and Applications
  Technology Networks Cell science 2023
  +Save
• X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc).
  Annals of the rheumatic diseases 2021 12 citations DOI: 10.1136/annrheumdis-2020-219822
  +Save
• Cellular and molecular mechanisms in fibrosis.
  Experimental dermatology 2020 109 citations DOI: 10.1111/exd.14193
  +Save
• Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis.
  Science translational medicine 2020 52 citations DOI: 10.1126/scitranslmed.aaz5506
  +Save
• Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis.
  Nature communications 2017 357 citations DOI: 10.1038/s41467-017-01236-6
  +Save